Traditional Chinese drugmakers prep to invade the West

The makers of traditional Chinese medicines are preparing for the world stage. The 7th World Congress of Chinese Medicine in Xinhua last week carried an unlikely theme that included such phrases as "clinical practice" and "scientific research."

Presentation titles did little to mask the ambitions of medicine makers. "Technical requirements for registration of Chinese medicine in the EU" and "Quality control of Chinese medicine" were among them.

And their efforts are hardly restricted to manufacturing topics: they are intent on proving the benefit of their treatments. Efforts are under way to create clinical trial protocols for traditional medicines that acknowledge their custom nature while meeting the proof standards of Western drug regulators.

- here's the article

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.